TAS-102 and Anlotinib in ≥3 Lines mGC
Clinical trial NCT05029102 · UNKNOWN
Trial details
- NCT number
- NCT05029102
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2024-12-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.